News
U.S. Advises Older Travelers to Avoid Chikungunya Vaccine
TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible side effects. The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) issued the warning late last week.
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
ABS-CBN on MSN31m
Dengue, chikungunya may soon be endemic in Europe: researchThe feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these ...
1don MSN
Most stories of chikungunya begin with something oddly harmless — a slight twitch in the toes or fingers. That’s when the ...
The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths. About 80,000 Ixchiq doses have ...
FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...
The US Centers for Disease Control and Prevention (CDC) is warning people planning to travel to the Region of the Indian ...
A total of 19,901 dengue cases have been reported in the country so far this year, according to the National Dengue Control ...
The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback